Albert Bourla - Feb 23, 2024 Form 4 Insider Report for PFIZER INC (PFE)

Role
Chairman & CEO, Director
Signature
Susan E. Grant, by power of atty., for Albert Bourla
Stock symbol
PFE
Transactions as of
Feb 23, 2024
Transactions value $
$421,477
Form type
4
Date filed
2/27/2024, 01:46 PM
Previous filing
Feb 16, 2024
Next filing
Feb 28, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PFE Common Stock Options Exercise $3.49M +128K +40.91% $27.34 440K Feb 23, 2024 Direct F1
transaction PFE Common Stock Tax liability -$245K -8.83K -2.01% $27.76 431K Feb 23, 2024 Direct F2
transaction PFE Common Stock Tax liability -$2.82M -103K -23.94% $27.37 328K Feb 23, 2024 Direct F3, F4
holding PFE Common Stock 4.75K Feb 23, 2024 By Rule 16b-3 Plan

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PFE Stock Appreciation Rights Options Exercise $0 -128K -100% $0.00* 0 Feb 23, 2024 Common Stock 128K $27.34 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
F2 The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
F3 The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
F4 Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.